Methoxyflurane Analgesia for Paediatric Injuries (MAGPIE)
A Randomised, Double-blind, Multicentre, Placebo Controlled Study to Evaluate the Safety and Efficacy of Methoxyflurane (PENTHROX®) for the Treatment of Acute Pain in Children and Adolescents from 6 to Less Than 18 Years of Age (presenting to an Emergency Department with Minor Trauma)
Sponsor: Medical Developments International Limited
A PHASE3 clinical study on Pain, Acute, this trial is completed. The trial is conducted by Medical Developments International Limited and has accumulated 13 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE3
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Oct 2021 — Sep 2023 [monthly]
Recruiting PHASE3
▶ Show 8 earlier versions
-
Mar 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE3
Status: Suspended → Recruiting
-
Apr 2020 — Oct 2020 [monthly]
Suspended PHASE3
Status: Recruiting → Suspended
-
Apr 2019 — Apr 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medical Developments International Limited
- Pediatric Emergency Research in the UK and Ireland (PERUKI)
- Quintiles, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .